Qsemble Capital Management, LP Charles River Laboratories International, Inc. Transaction History
Qsemble Capital Management, LP
- $751 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
699Shares Held
51.6MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$948 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$784 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$628 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$328 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$299 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.83B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...